Recently were published a results of new GLP Toxicity Study for ECHO-7 oncolytic virus Rigvir.
Total duration of the study was two years and ended in late 2020. The results reaffirmed the high level of patient safety using Rigvir and results show that there were no significant test item-related adverse events. This study was made by Charles River Laboratories Edinburgh, UK. Who are a leading scientific study company worldwide.
Link to publication:
© 2021 International Virotherapy Center Limited. All Rights Reserved